Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study

Background: Subcutaneous immunoglobulin G (SCIG) may be a better option than intravenous immunoglobulin G (IVIG) for patients with primary immunodeficiencies (PID) due to reduced systemic and serious adverse reactions and easier administration. The Infusione Bimensile di Immunoglobuline Sottocute (I...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pediatr Allergy Immunol Pulmonol
Main Authors: Canessa, Clementina, Gallo, Vera, Pignata, Claudio, Trizzino, Antonino, Graziani, Simona, Martire, Baldassarre, Moschese, Viviana, Palladino, Valentina, Boggia, Giorgio Maria, Matucci, Andrea, Pecoraro, Antonio, Spadaro, Giuseppe, Vultaggio, Alessandra, Azzari, Chiara
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2019
Assuntos:
Brief Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6733055/
https://ncbi.nlm.nih.gov/pubmed/31508259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ped.2018.0967
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares